Close Menu

NEW YORK (360Dx) –Inova Diagnostics said today that it received clearance from the US Food and Drug Administration for use of the Quanta Flash HMGCR marker, which aids in the diagnosis of idiopathic inflammatory myopathy (IIM), a group of conditions that affect the skeletal muscles and can lead to progressive muscle weakness, including tissue necrosis and disability.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.